Stocktoria
Vanda Pharmaceuticals Inc. VNDA
Vanda Pharmaceuticals Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 8,138,252 | $46.0M | 13.77% |
| AQR CAPITAL MANAGEMENT LLC | 3,497,695 | $21.4M | 5.92% |
| RENAISSANCE TECHNOLOGIES LLC | 3,441,361 | $21.1M | 5.82% |
| MILLENNIUM MANAGEMENT LLC | 1,602,813 | $9.8M | 2.71% |
| TWO SIGMA INVESTMENTS, LP | 1,349,072 | $8.3M | 2.28% |
| CITADEL ADVISORS LLC | 850,402 | $5.2M | 1.44% |
| Point72 Asset Management, L.P. | 311,362 | $1.9M | 0.53% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.